FDA, Markets
FDA Delays KalVista Drug Review for HAE
50% center coverage3 sources
FDA
First 100 Days
See how you scored in predicting Trump's first 100 days
Latest News
FDA
Dyne Therapeutics Receives FDA Breakthrough Designation for DM1 Treatment
100% left coverage1 source
FDA
Dyne Therapeutics Receives FDA Breakthrough Designation for DM1 Treatment
100% left coverage1 source
FDA
FDA Accepts Aquestive New Drug Application for Oral Epinephrine
100% left coverage1 source
FDA
FDA Accepts Aquestive New Drug Application for Oral Epinephrine
100% left coverage1 source
FDA, Markets
FDA Clears Amended Ocugen Trial for Stargardt Disease
50% center coverage2 sources
FDA, Markets
FDA Clears Amended Ocugen Trial for Stargardt Disease
50% center coverage2 sources
FDA
FDA Approves Pembrolizumab for Resectable Locally Advanced Head Neck Cancer
100% left coverage1 source
FDA
FDA Approves Pembrolizumab for Resectable Locally Advanced Head Neck Cancer
100% left coverage1 source
FDA, Markets
FDA Delays KalVista Drug Review for HAE
50% center coverage3 sources
FDA, Markets
FDA Delays KalVista Drug Review for HAE
50% center coverage3 sources
FDA, Markets
UroGen's ZUSDURI Approved, Faces Lawsuit After Surge
50% center coverage2 sources
FDA, Markets
UroGen's ZUSDURI Approved, Faces Lawsuit After Surge
50% center coverage2 sources
FDA, Food & Drink
US FDA Approves Wildtype Lab-Grown Salmon for Public Consumption
100% right coverage1 source
FDA, Food & Drink
US FDA Approves Wildtype Lab-Grown Salmon for Public Consumption
100% right coverage1 source
First 100 Days
See how you scored in predicting Trump's first 100 days
Most Reported By
News from FDA
News from FDA